Robert Mahley, Gladstone Institutes (IMAGE)

Gladstone Institutes

Robert Mahley, Gladstone Institutes

Caption

Dr. Mahley will use the Seeding Drug Discovery award to fast track the identification of chemical compounds that can correct the structure of apoE4—the biggest genetic risk factor for developing Alzheimer's disease.

Credit

Chris Goodfellow/Gladstone Institutes

Usage Restrictions

Please see Gladstone Press Relations for reprint permissions.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.